An Alternative to Intellectual Property Laws in Pharmacogenomics: The Open Source Model

By:
Prof Julia Gladstone
To add a paper, Login.

The completion of a high quality comprehensive sequence of the human genome has lead to the discovery of genetic links to complex diseases and the development of target drugs. Population databases which have been used in research for many decades can now be analyzed for genetic variations at the DNA level and links to simple and complex diseases can be made. Population genetic databases (PGDs) are a powerful resource to the systematic study of the genetic component of disease; the benefits to society from this science are far reaching.Through an analysis of current database protection laws, patent law and the open source biotechnology movement this paper examines how laws and norms can impact innovation in the field of pharmacogenomics.


Keywords: Genomics, Intellectual Property, Databases, Open Source
Stream: Cyberspace, Technology, Science, Environment and the Humanities
Presentation Type: Virtual Presentation in English
Paper: Alternative to Intellectual Property Laws in Pharmacogenomics, An


Prof Julia Gladstone

Professor, Legal Studies, Bryant University
Smithfield, RI, USA

Julia Alpert Gladstone is an Associate Professor of Law at Bryant University where she teaches multidisciplinary courses which intertwine with the law. Her research examines the dynamic between law and technology which is revealed in the areas of intellectual property and privacy law. She has published in several areas of intellectual property law primarily focusing on the database phenomenon as it has emerged in the field of genomics.

Ref: H06P0555